The study will be a 6 to 9-week study, including a 1-to 4-week (dependent on duration of washout period) Screening Period, followed by a 4-week double blind, randomized, placebo-controlled Treatment Period, and a 1-week Follow Up Period. Subjects eligible for the study will randomize to receive either NYX-2925 or placebo for 4 weeks.